文献速递系统性红斑狼疮

WHO狼疮抗双链DNA抗体参考试剂的国际协作研究

A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation.
PubMed 文献 · Ann Rheum Dis · 2019-09-05

针对首个WHO抗dsDNA国际标准品耗尽的问题,研究将一名SLE患者血浆制备为候选参考品15/174,并在17个国家36个实验室进行国际协作研究。结果显示15/174有助于改善不同检测方法间的性能差异,但未能证明其与首个国际标准品等效,最终被确立为WHO狼疮(寡特异性)抗dsDNA抗体参考试剂,标称值100单位/安瓿。

要点

  • 15/174被确立为WHO参考试剂,标称值100单位/安瓿,用于对齐抗dsDNA抗体定量检测方法。
  • 15/174不能被认为与首个抗dsDNA国际标准品Wo/80等效。
  • 研究未显示具有统计学意义的总体效价、检测平行性或互换性。

核心结论

  • 15/174不能被认为与首个抗dsDNA国际标准品Wo/80等效,被确立为WHO狼疮(寡特异性)抗dsDNA抗体参考试剂,标称值100单位/安瓿。

研究设计与样本

  • SLE患者血浆先在42家欧洲实验室评估,后由NIBSC制备为候选WHO参考品15/174。
  • 国际协作研究纳入17个国家36家实验室。

主要发现

  • 血浆主要含抗dsDNA、其他抗染色质抗体和抗Ku抗体。
  • 国际协作研究显示15/174作为共同参考试剂有助于改善不同检测方法间的性能差异。
  • 未显示具有统计学意义的总体效价、检测平行性或互换性。

关键数值与推荐

  • 15/174标称值为100单位/安瓿。
  • 15/174不能被认为与首个抗dsDNA国际标准品Wo/80等效。

临床怎么用

  • 15/174拟用于对齐量化抗dsDNA抗体水平的检测方法。

局限性

  • 未显示具有统计学意义的总体效价、检测平行性或互换性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Antibodies against double-stranded DNA (anti-dsDNA) are a specific biomarker for systemic lupus erythematosus (SLE). The first WHO International Standard (IS) for anti-dsDNA (established in 1985), which was used to assign units to diagnostic tests, was exhausted over a decade ago. METHODS: Plasma from a patient with SLE was first evaluated in 42 European laboratories. The plasma was thereafter used by the National Institute for Biological Standards and Control to prepare a candidate WHO reference preparation for lupus (anti-dsDNA) antibodies. That preparation, coded 15/174, was subjected to an international collaborative study, including 36 laboratories from 17 countries. RESULTS: The plasma mainly contained anti-dsDNA, other anti-chromatin antibodies and anti-Ku. The international collaborative study showed that the field would benefit from 15/174 as a common reference reagent improving differences in performance between different assays. However, no statistically meaningful overall potency or assay parallelism and commutability could be shown. CONCLUSION: 15/174 cannot be considered equivalent to the first IS for anti-dsDNA (Wo/80) and was established as a WHO Reference Reagent for lupus (oligo-specific) anti-dsDNA antibodies with a nominal value of 100 units/ampoule. This preparation is intended to be used to align test methods quantifying levels of anti-dsDNA antibodies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Fox BJ, Hockley J, Rigsby P, et al. A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation. Ann Rheum Dis. 2019. PMID: 31488407. doi:10.1136/annrheumdis-2019-215845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。